{
 "PrintNo":"A9265","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2022-02-09T09:22:52.299766Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-02-09","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2022-02-09","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":662,"Name":"John T. McDonald III","Short":"MCDONALD"},{"ID":675,"Name":"Phil Steck","Short":"STECK"}],
 "Title":"Requires notice of adverse step therapy determinations",
 "Summary":"Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination.",
 "LawSection":"Insurance Law","LawCode":"Amd §§4902 & 4903, Ins L; amd §§4902 & 4903, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to requiring notice of adverse step therapy determinations",
 "SameAsPrintNo":"S8194-2021"
}